Our Website Uses Cookies
We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.
For more information, please contact us or consult our Privacy Notice.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
Covington’s health information privacy lawyers are at the center of the debate regarding the privacy of medical records and other individually identifiable health information. We have developed extensive expertise on matters of health information privacy, working on these issues from the perspective both of affected entities and government regulators. We serve a broad client base of healthcare providers, pharmaceutical companies, benefit managers, group health plans, clinical laboratories, medical equipment manufacturers, and others whose businesses involve the handling of personal health information.
We routinely counsel clients regarding compliance with the privacy standards promulgated under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Health Information Technology for Clinical and Economic Health (HITECH) Act. We have assisted in our clients’ efforts to obtain amendments to, or clarifications of, these regulations. We also counsel our clients on state laws affecting the privacy of health information, such as genetic information and pharmacy records, and we regularly provide advice on the interaction between state law and the federal regulations governing the privacy of health information.
We often assist clients in the United States and Europe engaging in clinical trials and post-marketing research activities and have been involved in preparing informed consent forms, investigator disclosure documents, contract research organization (CRO) agreements, clinical trial agreements and service provider agreements. We also assist companies in the healthcare industry with privacy issues relating to websites and live webcasts. Additionally, we have performed due diligence regarding healthcare privacy issues on behalf of venture capitalists and other entities interested in acquiring or investing in healthcare companies.
Our London- and Brussels-based lawyers have acquired unparalleled expertise in the unique privacy issues facing the pharmaceutical industry in Europe. We have been called upon to advise on the national rules in several European jurisdictions relating to the use of “biobanks” and research databases, privacy issues resulting from mandatory pharmacovigilance and adverse event reporting, key-coding of data, and the “further use” of data collected during clinical trials.
In Asia, we have assisted pharmaceutical companies operating in China with unique privacy issues, including advising privacy and property ownership issues related to the collection and sharing of biological samples in clinical trials.
GDPR Planning and Preparation Conference for Employers
March 30, 2017, Business Forums International Ltd.
December 15, 2016, CCT News
Daniel Cooper is quoted by CCT News in an article regarding the use of wearable technology in the workplace. According to Cooper, the use of wearable devices is a good way, especially for insurers. However, the wearers’ privacy must be taken care of as well as their legitimate treatment concerns.
Wearable technology: gathering data from tooth to toe
November 21, 2016, Financial Times
Daniel Cooper is quoted in a Financial Times article regarding wearable technology in the workplace. According to Cooper, not everyone will welcome sharing intimate personal information with the boss, however. “Wearable devices could be a good way for insurers to get the data . . . but it’s essential to address wearers’ privacy and fair treatment concerns and ...